China halts research team's work on gene-edited babies - Action News
Home WebMail Saturday, November 23, 2024, 03:51 PM | Calgary | -11.6°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
World

China halts research team's work on gene-edited babies

China's government orders a halt to work by a medical team that claims it helped make the world's first gene-edited babies, as a group of leading scientists declared it's still too soon to try to make permanent changes to DNA that can be inherited by future generations.

Researcher He Jiankui claims his team edited the genes of twin girls born this month

China's government said Thursday it had ordered a halt to work by researcher He Jiankui's medical team. He claimed earlier this week that his team helped make the world's first genetically edited babies. (Mark Schiefelbein/Associated Press)

China's government on Thursday ordereda halt to work by a medical team that claims it helped make the world's first gene-edited babies, as a group of leading scientists declared it's still too soon to try to make permanent changes to DNA that can be inherited by future generations.

Xu Nanping,China's vice-minister of science and technology,told state broadcaster CCTV that his ministry is strongly opposed to the team's efforts, which reportedly produced twin girls born earlier this month.

Xu called the team's actions illegal and unacceptable, and said an investigation hasbeen ordered, but made no mention of specific actions taken.

Researcher He Jiankui claims to have altered the DNA of the twins to try to make them resistant to infection with the AIDS virus.

Mainstream scientists have condemned the experiment, and universities and government groups are investigating.

He's experiment "crossed the line of morality and ethics adhered to by the academic community, and was shocking and unacceptable," Xu said.

A researcher installs a fine glass pipette into a sperm injection microscope, in preparation for injecting embryos with Cas9 protein and PCSK9 sgRNA, at a lab in Shenzhen in southern China's Guandong province last month. (Mark Schiefelbein/Associated Press)

A group of leading scientists gathered in Hong Kong this week for an international conference on gene editing, the ability to rewrite the code of life to try to correct or prevent diseases.

Although the science holds promise for helping people already born and studies testing that are underway, a statement issued Thursday by the 14-member conference leaders says it's irresponsible to try it on eggs, sperm or embryos except in lab research because not enough is known yet about its risks or safety.

Claims still unconfirmed

The conference was rocked by the Chinese researcher's claim hehelped make the world's first gene-edited babies. Conference leaders called for an independent investigation of the claim by He, who spoke to the group Wednesday as international criticismmounted.

There is no independent confirmation of what He says he did.

He was scheduled to speak again at the conference on Thursday, but left Hong Kong, and through a spokesperson he sent a statement saying, "I will remain in China, my home country, and co-operate fully with all inquiries about my work. My raw data will be made available for third party review."

A microplate containing embryos injected with Cas9 protein, in a laboratory in Shenzhen on Oct. 9. (Mark Schiefelbein/Associated Press)

Several prominent scientists said the case showed a failure of the field to police itself and the need for stricter principles or regulations.

"It's not unreasonable to expect the scientific community" to follow guidelines, said David Baltimore, a Nobel laureate from the California Institute of Technology who led the panel.

There already are some rules that should have prevented what He says he did, said Alta Charo, a University of Wisconsin lawyer and bioethicist, and a conference organizer.

"I think the failure was his, not the scientific community," Charo said.

Gene editing for reproductive purposes might be considered in the future,"but only when there is compelling medical need" with clear understanding of risks and benefits, and certain other conditions, said Dr. Victor Dzau, president of the U.S. National Academy of Medicine, one of the conference sponsors.

"Not following these guidelines would be an irresponsible act," he said.

Other sponsors of the three-day conference are the Academy of Sciences of Hong Kong, the Royal Society of the United Kingdom and the U.S. National Academy of Sciences.